Perovskite Photon Counting X-ray Detectors for Medical Imaging.
Clarity Sensors is developing advanced photon-counting detectors using halide perovskite semiconductors to enhance X-ray imaging resolution while reducing radiation dose, aiming for widespread adoption in clinical settings.
Projectdetails
Introduction
X-ray imaging is a crucial diagnostic tool in modern medicine, with 3.6 billion examinations performed annually. However, X-rays are carcinogenic and pose health risks if not carefully managed. Current detectors used in X-ray imaging and CT scanners prevent advances in image resolution and reduction in radiation dose, limiting screening programs and early disease detection.
Photon-Counting CT Systems
Photon-counting CT (PCCT) systems, which have recently entered the market, offer significant health benefits and present a promising path toward more widespread preventative imaging. However, the adoption of PCCT technology has been slow, primarily due to the energy-intensive and complex fabrication processes of first-generation materials.
Need for Next-Generation Detectors
There is an urgent need for next-generation photon-counting detectors (PCDs) that can:
- Reduce radiation dose
- Improve image resolution
- Streamline manufacturing
Clarity Sensors
Clarity Sensors, a University of Cambridge spin-off, is developing advanced PCDs with halide perovskite semiconductors. Our patented monolithic integration process, combined with leading perovskite quality, positions Clarity Sensors to deliver industry-leading PCDs, targeting the highest image resolution and lowest effective dose, enabling 100 times more scans at the same radiation level.
Project Developments
Through projects such as our ERC Proof-of-Concept (PEROVSCI), we have demonstrated a stable, single-pixel halide perovskite PCD and filed key IP culminating in the fabrication of the first monolithic perovskite PCD on a multi-pixel ASIC.
Future Plans
In PERFORM, we will further develop our technology and business operations to position Clarity Sensors for investment and joint development. This will include:
- Optimising our current PCD systems
- Developing our working demonstrator, PRISM-X, which will be validated against commercial technologies in clinical settings to reach TRL5
- Expanding our technical and commercial team
- Securing additional IP
- Engaging target customers
- Initiating joint-development agreements
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.494.268 |
Totale projectbegroting | € 2.494.268 |
Tijdlijn
Startdatum | 1-6-2025 |
Einddatum | 31-5-2028 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- CLARITY SENSORS LIMITEDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Low-power consumption, heavy-metal-free wide-spectrum image sensors for mass-market computer vision applicationsQSTACK aims to develop a power-efficient, heavy-metal-free wide-spectrum image sensor technology to enhance computer vision applications, boosting the European semiconductor industry's competitiveness. | EIC Transition | € 2.370.937 | 2023 | Details |
Photoacoustic imaging and artificial intelligence-based theranostic approach for cancerPHIRE aims to develop a novel theranostic device for high-resolution imaging and treatment of bladder cancer lesions under 1 mm, improving patient outcomes and reducing tumor relapse. | EIC Transition | € 2.084.871 | 2023 | Details |
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid TumoursScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027. | EIC Transition | € 2.499.911 | 2025 | Details |
Low-power consumption, heavy-metal-free wide-spectrum image sensors for mass-market computer vision applications
QSTACK aims to develop a power-efficient, heavy-metal-free wide-spectrum image sensor technology to enhance computer vision applications, boosting the European semiconductor industry's competitiveness.
Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer
PHIRE aims to develop a novel theranostic device for high-resolution imaging and treatment of bladder cancer lesions under 1 mm, improving patient outcomes and reducing tumor relapse.
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid Tumours
ScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Toward next-generation X-ray imaging: Pb-free PErovskite Charge Transport engineeringX-PECT aims to develop sustainable, lead-free metal halide perovskite X-ray detectors with enhanced sensitivity and stability to reduce radiation exposure in medical and security applications. | ERC Starting... | € 2.035.525 | 2024 | Details |
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields. | ERC Advanced... | € 3.351.875 | 2024 | Details |
Cherenkov light for total-body Positron Emission TomographyThe project aims to develop a cost-effective, high-performance PET scanner using Cherenkov photon detection to enhance early cancer diagnosis and treatment monitoring. | ERC Proof of... | € 150.000 | 2023 | Details |
NEW TECHNOLOGY FOR 1 MICRON RESOLUTION BIOMEDICAL IMAGINGThe 1MICRON project aims to revolutionize cancer detection by developing high-resolution, integrated x-ray sensors for immediate surgical feedback, potentially saving over 100,000 treatments annually in Europe. | EIC Pathfinder | € 2.999.999 | 2025 | Details |
Next generation Limited-Angle time-of-flight PET imagerThe PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings. | EIC Pathfinder | € 3.374.041 | 2023 | Details |
Toward next-generation X-ray imaging: Pb-free PErovskite Charge Transport engineering
X-PECT aims to develop sustainable, lead-free metal halide perovskite X-ray detectors with enhanced sensitivity and stability to reduce radiation exposure in medical and security applications.
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.
This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields.
Cherenkov light for total-body Positron Emission Tomography
The project aims to develop a cost-effective, high-performance PET scanner using Cherenkov photon detection to enhance early cancer diagnosis and treatment monitoring.
NEW TECHNOLOGY FOR 1 MICRON RESOLUTION BIOMEDICAL IMAGING
The 1MICRON project aims to revolutionize cancer detection by developing high-resolution, integrated x-ray sensors for immediate surgical feedback, potentially saving over 100,000 treatments annually in Europe.
Next generation Limited-Angle time-of-flight PET imager
The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.